Reata Pharmaceuticals Inc buy melinda
Summary
This prediction ended on 20.04.18 with a price of €19.00. With a performance of 5.56%, the BUY prediction by melinda for Reata Pharmaceuticals Inc closed with a slight gain. melinda has 50% into this predictionReata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on identifying, developing, and commercializing novel therapeutics for patients with severe and life-threatening diseases. The company's primary business areas include drug discovery and development in fields such as cardiovascular, fibrotic, mitochondrial, and neurodegenerative diseases. With a strong emphasis on research and innovation, Reata Pharmaceuticals seeks to deliver cutting-edge treatments that address unmet medical needs, improve patient outcomes, and significantly impact the lives of those suffering from rare and debilitating conditions. As a publicly traded company, Reata Pharmaceuticals is listed on the NASDAQ stock exchange under the ticker symbol "RETA."
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Reata Pharmaceuticals Inc | - | - | - | - |
iShares Core DAX® | 1.851% | 5.158% | 17.711% | 19.954% |
iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% | 56.636% |
iShares Nikkei 225® | -0.412% | -2.857% | 13.501% | 7.721% |
iShares S&P 500 | 1.128% | 2.485% | 29.871% | 47.507% |
Comments by melinda for this prediction
In the thread Reata Pharmaceuticals Inc diskutieren
Pharma
A +
Stopped prediction by melinda for Reata Pharmaceuticals Inc
Reata Pharmaceuticals Inc
17.04.23
17.04.24
18.04.24